Genetic therapies for cardiovascular diseases

Luis G. Melo, Alok S. Pachori, Massimiliano Gnecchi, Victor J. Dzau

Research output: Contribution to journalArticle

Abstract

Recent advances in understanding the molecular and cellular basis of cardiovascular diseases, together with the availability of tools for genetic manipulation of the cardiovascular system, offer possibilities for new treatments. Gene therapies have demonstrated potential usefulness for treating complex cardiovascular diseases, such as hypertension, atherosclerosis and myocardial ischemia, in various animal models. Some of these experimental therapies are now undergoing clinical evaluation in patients with cardiovascular disease. However, the successful transition of these therapies into mainstream clinical practice awaits further improvements to vector platforms and delivery tools and the documentation of clinical feasibility, safety and efficacy through multi-center randomized trials.

Original languageEnglish
Pages (from-to)240-250
Number of pages11
JournalTrends in Molecular Medicine
Volume11
Issue number5
DOIs
Publication statusPublished - May 2005

Fingerprint

Genetic Therapy
Cardiovascular Diseases
Investigational Therapies
Cardiovascular System
Documentation
Myocardial Ischemia
Atherosclerosis
Animal Models
Hypertension
Safety
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Genetic therapies for cardiovascular diseases. / Melo, Luis G.; Pachori, Alok S.; Gnecchi, Massimiliano; Dzau, Victor J.

In: Trends in Molecular Medicine, Vol. 11, No. 5, 05.2005, p. 240-250.

Research output: Contribution to journalArticle

Melo, Luis G. ; Pachori, Alok S. ; Gnecchi, Massimiliano ; Dzau, Victor J. / Genetic therapies for cardiovascular diseases. In: Trends in Molecular Medicine. 2005 ; Vol. 11, No. 5. pp. 240-250.
@article{56ba30f246524263b9467875492d1ea3,
title = "Genetic therapies for cardiovascular diseases",
abstract = "Recent advances in understanding the molecular and cellular basis of cardiovascular diseases, together with the availability of tools for genetic manipulation of the cardiovascular system, offer possibilities for new treatments. Gene therapies have demonstrated potential usefulness for treating complex cardiovascular diseases, such as hypertension, atherosclerosis and myocardial ischemia, in various animal models. Some of these experimental therapies are now undergoing clinical evaluation in patients with cardiovascular disease. However, the successful transition of these therapies into mainstream clinical practice awaits further improvements to vector platforms and delivery tools and the documentation of clinical feasibility, safety and efficacy through multi-center randomized trials.",
author = "Melo, {Luis G.} and Pachori, {Alok S.} and Massimiliano Gnecchi and Dzau, {Victor J.}",
year = "2005",
month = "5",
doi = "10.1016/j.molmed.2005.03.008",
language = "English",
volume = "11",
pages = "240--250",
journal = "Trends in Molecular Medicine",
issn = "1471-4914",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Genetic therapies for cardiovascular diseases

AU - Melo, Luis G.

AU - Pachori, Alok S.

AU - Gnecchi, Massimiliano

AU - Dzau, Victor J.

PY - 2005/5

Y1 - 2005/5

N2 - Recent advances in understanding the molecular and cellular basis of cardiovascular diseases, together with the availability of tools for genetic manipulation of the cardiovascular system, offer possibilities for new treatments. Gene therapies have demonstrated potential usefulness for treating complex cardiovascular diseases, such as hypertension, atherosclerosis and myocardial ischemia, in various animal models. Some of these experimental therapies are now undergoing clinical evaluation in patients with cardiovascular disease. However, the successful transition of these therapies into mainstream clinical practice awaits further improvements to vector platforms and delivery tools and the documentation of clinical feasibility, safety and efficacy through multi-center randomized trials.

AB - Recent advances in understanding the molecular and cellular basis of cardiovascular diseases, together with the availability of tools for genetic manipulation of the cardiovascular system, offer possibilities for new treatments. Gene therapies have demonstrated potential usefulness for treating complex cardiovascular diseases, such as hypertension, atherosclerosis and myocardial ischemia, in various animal models. Some of these experimental therapies are now undergoing clinical evaluation in patients with cardiovascular disease. However, the successful transition of these therapies into mainstream clinical practice awaits further improvements to vector platforms and delivery tools and the documentation of clinical feasibility, safety and efficacy through multi-center randomized trials.

UR - http://www.scopus.com/inward/record.url?scp=18844421599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844421599&partnerID=8YFLogxK

U2 - 10.1016/j.molmed.2005.03.008

DO - 10.1016/j.molmed.2005.03.008

M3 - Article

C2 - 15882612

AN - SCOPUS:18844421599

VL - 11

SP - 240

EP - 250

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

SN - 1471-4914

IS - 5

ER -